Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Personalized Medicine Is Closer Than You Think, FDA’s Throckmorton Says

Executive Summary

Personalized medicine should be adopted as a prospective strategy in drug development rather than primarily serving as a tool to salvage failing drug candidates, participants at FDA's Science Forum suggested

You may also be interested in...



AstraZeneca Personalized Medicine Team has 10 Projects In The Clinic - McHale

Duncan McHale joined the firm in May as personalized health care medical director.

Personalized Medicine Requires Specialized Clinical Trial Design – BIO Panel

To better establish personalized medicine as a practical strategy, sponsors should begin designing and conducting clinical trials with that goal in mind, speakers on a panel at the BIO International Convention recommend

Personalized Medicine Requires Specialized Clinical Trial Design – BIO Panel

To better establish personalized medicine as a practical strategy, sponsors should begin designing and conducting clinical trials with that goal in mind, speakers on a panel at the BIO International Convention recommend

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS047160

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel